IRIS Accounts Production v24.3.2.46 10104040 director 1.6.23 31.5.24 31.5.24 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101040402023-05-31101040402024-05-31101040402023-06-012024-05-31101040402022-05-31101040402022-06-012023-05-31101040402023-05-3110104040ns15:EnglandWales2023-06-012024-05-3110104040ns14:PoundSterling2023-06-012024-05-3110104040ns10:Director12023-06-012024-05-3110104040ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3110104040ns10:SmallEntities2023-06-012024-05-3110104040ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3110104040ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3110104040ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3110104040ns10:FullAccounts2023-06-012024-05-3110104040ns10:RegisteredOffice2023-06-012024-05-3110104040ns5:CurrentFinancialInstruments2024-05-3110104040ns5:CurrentFinancialInstruments2023-05-3110104040ns5:Non-currentFinancialInstruments2024-05-3110104040ns5:Non-currentFinancialInstruments2023-05-3110104040ns5:ShareCapital2024-05-3110104040ns5:ShareCapital2023-05-3110104040ns5:RetainedEarningsAccumulatedLosses2024-05-3110104040ns5:RetainedEarningsAccumulatedLosses2023-05-3110104040ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3110104040ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-31101040401ns10:Director12023-05-31101040401ns10:Director12022-05-31101040401ns10:Director12023-06-012024-05-31101040401ns10:Director12022-06-012023-05-31101040401ns10:Director12024-05-31101040401ns10:Director12023-05-31
REGISTERED NUMBER: 10104040 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2024

FOR

CARDIOVASCULAR ADVISORS LTD.

CARDIOVASCULAR ADVISORS LTD. (REGISTERED NUMBER: 10104040)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CARDIOVASCULAR ADVISORS LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2024







DIRECTOR: Prof C N McCollum





REGISTERED OFFICE: The Lodge
858 Wilmslow Road
Didsbury
Manchester
Lancashire
M20 2AU





REGISTERED NUMBER: 10104040 (England and Wales)





ACCOUNTANTS: Wyatt Morris Golland Ltd
Park House
200 Drake Street
Rochdale
Lancashire
OL16 1PJ

CARDIOVASCULAR ADVISORS LTD. (REGISTERED NUMBER: 10104040)

BALANCE SHEET
31 MAY 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 660,926 832,151
Cash at bank 372 273
661,298 832,424
CREDITORS
Amounts falling due within one year 5 - 146,959
NET CURRENT ASSETS 661,298 685,465
TOTAL ASSETS LESS CURRENT
LIABILITIES

661,298

685,465

CREDITORS
Amounts falling due after more than one year 6 - 24,167
NET ASSETS 661,298 661,298

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 661,098 661,098
SHAREHOLDERS' FUNDS 661,298 661,298

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 February 2025 and were signed by:





Prof C N McCollum - Director


CARDIOVASCULAR ADVISORS LTD. (REGISTERED NUMBER: 10104040)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1. STATUTORY INFORMATION

Cardiovascular Advisors Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 2 ).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed by group undertakings 660,863 832,151
Other debtors 63 -
660,926 832,151

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts - 48,399
Trade creditors - 25,533
Taxation and social security - 73,027
- 146,959

CARDIOVASCULAR ADVISORS LTD. (REGISTERED NUMBER: 10104040)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2024

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans - 24,167

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2024 and 31 May 2023:

2024 2023
£    £   
Prof C N McCollum
Balance outstanding at start of year - 195,311
Amounts repaid - (195,311 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

8. RELATED PARTY DISCLOSURES

At the year end the holding company McCollum Consultants Ltd owed £660,863 included in debtors.

9. ULTIMATE CONTROLLING PARTY

The controlling party is McCollum Consultants Limited.